August 2018
Earle A. Chiles Research Institute, a division of Providence Cancer Institute in the Robert W. Franz Cancer Center, is currently conducting more than 125 research studies, including clinical trials of targeted therapies and novel immunotherapy approaches.
Phase 1 immunotherapy trials
Phase 1 studies are the springboard for advancing new cancer treatments. Providence Cancer Institute o ffers many phase 1 trials for multiple cancer types, including two new studies for people with head and neck cancer and melanoma:

All current open studies:
Find additional studies for many types of cancer in Multiple Tumor Types .
New studies are posted frequently - please check our  website  for a complete list of our current studies. For more information, call 503-215-2614.